Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

August 1975

Volume 255 Chemistry, Biology, and Clinical Use of Nucleoside Analogs

Pages 3–610

  1. PART I. CHEMISTRY OF NUCLEOSIDE ANALOGS

    1. Top of page
    2. PART I. CHEMISTRY OF NUCLEOSIDE ANALOGS
    3. PART II. CLINICAL USES OF NUCLEOSIDE ANALOGS
    4. PART III. BIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY OF NUCLEOSIDE ANALOGS
    1. FLUORESCENT NUCLEOSIDES AND NUCLEOTIDES (pages 43–58)

      Nelson J. Leonard and Glen L. Tolman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29212.x

    2. SYNTHESIS OF NUCLEOSIDES WITH USE OF TRIMETHYLSILYL-HETEROCYCLES (pages 82–90)

      Helmut Vorbrüggen, Konrad Krolikiewicz and Ulrich Niedballa

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29215.x

    3. SYNTHESIS AND REACTION OF SOME 6-SUBSTITUTED PYRIMIDINE NUCLEOSIDES (pages 121–130)

      Tohru Ueda, Hideo Inoue and Akira Matsuda

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29218.x

    4. SYNTHESIS AND EVALUATION OF ACYCLIC SUGAR NUCLEOSIDES (pages 131–150)

      Derek Horton, David C. Baker and Satish S. Kokrady

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29219.x

    5. SYNTHESIS OF CERTAIN 4′-SUBSTITUTED NUCLEOSIDES (pages 151–165)

      Julien P. H. Verheyden, Ian D. Jenkins, Geoffrey R. Owen, Slobodan D. Dimitrijevich, Colin M. Richards, Prem C. Srivastava, Nghiep Le-Hong and John G. Moffatt

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29220.x

  2. PART II. CLINICAL USES OF NUCLEOSIDE ANALOGS

    1. Top of page
    2. PART I. CHEMISTRY OF NUCLEOSIDE ANALOGS
    3. PART II. CLINICAL USES OF NUCLEOSIDE ANALOGS
    4. PART III. BIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY OF NUCLEOSIDE ANALOGS
    1. CLINICAL APPLICATION OF ADENINE ARABINOSIDE (pages 185–189)

      Ronald E. Keeney and Robert A. Buchanan

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29223.x

    2. NUCLEOSIDE ANALOGS IN THE TREATMENT OF NONNEOPLASTIC DISEASES (pages 190–201)

      Paul Calabresi, Charles H. Doolittle III, Gloria H. Heppner and Charles J. McDonald

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29224.x

    3. EXPERIMENTAL AND CLINICAL STUDIES ON NUCLEOSIDE ANALOGS AS ANTITUMOR AGENTS (pages 202–212)

      Joseph H. Burchenal, Violante E. Currie, Monroe D. Dowling, Jack J. Fox and Irwin H. Krakoff

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29225.x

    4. THE EFFECTS OF NUCLEOSIDE ANALOGS ON CUTANEOUS NEOPLASMS (pages 216–224)

      Edmund Klein, Gordon H. Burgess, Alexander Bloch, Halina Milgrom and Ole A. Holtermann

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29227.x

    5. CYTOKININS AS CHEMOTHERAPEUTIC AGENTS (pages 225–234)

      Arnold Mittelman, James T. Evans and Girish B. Chheda

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29228.x

    6. FURTHER CONSIDERATIONS IN THE THERAPY WITH ARA-C (pages 244–246)

      W. Kreis

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29230.x

    7. PHARMACOLOGICAL AND CLINICAL STUDIES OF SOME NUCLEOSIDE ANALOGS (pages 252–260)

      Ti Li Loo, D. H. W. Ho, Gerald P. Bodey and Emil J Freireich

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29232.x

    8. METHOTREXATE-THYMIDINE TREATMENT OF MURINE LEUKEMIA (pages 261–265)

      M. H. N. Tattersall, B. L. Brown and Emil Frei III

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29233.x

  3. PART III. BIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY OF NUCLEOSIDE ANALOGS

    1. Top of page
    2. PART I. CHEMISTRY OF NUCLEOSIDE ANALOGS
    3. PART II. CLINICAL USES OF NUCLEOSIDE ANALOGS
    4. PART III. BIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY OF NUCLEOSIDE ANALOGS
    1. THE UTILIZATION OF NUCLEOTIDES BY ANIMAL CELLS (pages 269–286)

      Seymour S. Cohen and William Plunkett

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29235.x

    2. OCCURRENCE OF DEAMINATED MONOPHOSPHATE NUCLEOTIDE IN EXTRACELLULAR SITES AFTER GIVING ARABINOFURANOSYLCYTOSINE OR DEOXYCYTIDINE TO MICE (pages 287–291)

      Ting-Chao Chou, Dorris J. Hutchison, Franz A. Schmid and Frederick S. Philips

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29236.x

    3. THE SYNTHESIS AND EVALUATION OF AZAPURINE NUCLEOSIDES AS CYTOTOXIC AGENTS (pages 292–305)

      J. A. Montgomery, R. D. Elliott and H. J. Thomas

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29237.x

    4. NUCLEOSIDE ANALOGS AS ANTIPARASITIC AGENTS (pages 306–316)

      Julian J. Jaffe

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29238.x

    5. SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME NOVEL ANALOGS OF THYMIDINE (pages 332–341)

      Yung-Chi Cheng, John P. Neenan, Barry Goz, David C. Ward and William H. Prusoff

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29241.x

    6. STUDIES ON THE BIOCHEMICAL BASIS FOR THE ANTIVIRAL ACTIVITIES OF SOME NUCLEOSIDE ANALOGS (pages 342–358)

      L. Lee Bennett Jr., W. M. Shannon, Paula W. Allan and G. Arnett

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29242.x

    7. EFFICACY OF RIBAVIRIN AGAINST INFLUENZA VIRUS IN TISSUE CULTURE AND IN MICE (pages 366–371)

      F. E. Durr and H. F. Lindh

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29244.x

    8. CARDIOVASCULAR EFFECTS OF NUCLEOSIDE ANALOGS (pages 380–389)

      Herman H. Stein, Pitambar Somani and Raj Nandan Prasad

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29246.x

    9. TRANSPORT OF NUCLEOSIDES (pages 402–411)

      Alan R. P. Paterson, S. Chong Kim, Ora Bernard and Carol E. Cass

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29248.x

    10. INCORPORATION OF ANALOG PURINE NUCLEOSIDES INTO THE FORMED ELEMENTS OF HUMAN BLOOD: ERYTHROCYTES, PLATELETS, AND LYMPHOCYTES (pages 412–434)

      R. E. Parks Jr., G. W. Crabtree, Chong M. Kong, R. P. Agarwal, K. C. Agarwal and E. M. Scholar

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29249.x

    11. CLINICAL AND EXPERIMENTAL STUDIES ON ADENINE, VARIOUS NUCLEOSIDES AND THEIR ANALOGS IN HEMATOLOGY (pages 435–467)

      J. L. Ambrus, C. M. Ambrus, K. Odake, I. B. Mink, R. Shields, W. Warner, C. Bishop, G. L. Tritsch, G. Golden and A. Mittelman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29250.x

    12. BIOLOGICAL ACTIVITIES OF SOME PURINE ARABINOSIDES (pages 468–480)

      Gertrude B. Elion, Janet L. Rideout, Paulo de Miranda, Peter Collins and D. J. Bauer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29251.x

    13. BIOCHEMICAL PHARMACOLOGY OF A NEW THIOPURINE NUCLEOSIDE DERIVATIVE (pages 481–488)

      G. A. LePage and S. Naik

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29252.x

    14. EFFECTS OF NUCLEOSIDE ANALOGS ON PURINE NUCLEOTIDE METABOLISM (pages 489–500)

      J. Frank Henderson, Camilla M. Smith, Floyd F. Snyder and George Zombor

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29253.x

    15. THE MECHANISM OF ACTION OF 3-DEAZAURIDINE IN TUMOR CELLS SENSITIVE AND RESISTANT TO ARABINOSYLCYTOSINE (pages 501–521)

      R. W. Brockman, Sue C. Shaddix, Marilyn Williams, J. Arly Nelson, Lucy M. Rose and Frank M. Schabel Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29254.x

    16. BIOCHEMICAL PROPERTIES OF 5-SULFUR-SUBSTITUTED PYRIMIDINE NUCLEOSIDES AND NUCLEOTIDES (pages 522–531)

      T. J. Bardos, J. Aradi, Y. K. Ho and T. I. Kalman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29255.x

    17. POLYNUCLEOTIDES CONTAINING 5-MERCAPTO-SUBSTITUTED PYRIMIDINES: INHIBITION OF VIRAL DNA POLYMERASES AND THE BIOLOGICAL IMPLICATION (pages 532–543)

      P. Chandra, U. Ebener, Thomas J. Bardos, P. Chakrabarti, Y. K. HO, A. J. Mikulski and A. Zsindely

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29256.x

    18. BIOCHEMISTRY AND BIOLOGICAL EFFECTS OF THE PYRAZOFURINS (PYRAZOMYCINS): INITIAL CLINICAL TRIAL (pages 544–551)

      Gerald E. Gutowski, Martin J. Sweeney, Donald C. DeLong, Robert L. Hamill, Koert Gerzon and Richard W. Dyke

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29257.x

    19. MECHANISMS OF HALOGENATED NUCLEOSIDE EMBRYOTOXICITY (pages 552–558)

      Richard G. Skalko and David S. Packard Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29258.x

    20. INHIBITION OF MICROORGANISMS BY PYRIMIDINE NUCLEOSIDES (pages 559–563)

      Bipin M. Mehta and Dorris J. Hutchison

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29259.x

    21. NUCLEOSIDES AND NUCLEOTIDES: PAST, PRESENT, AND FUTURE (pages 597–610)

      Roland K. Robins

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1975.tb29263.x

SEARCH

SEARCH BY CITATION